Trial · NCT01714310
Results by group216
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 216
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Clinical Global Impression-Severity-Severe Mood Dysregulation | Fluoxetine | Baseline | 4.91 | Standard Error .53 | units on a scale |
| Clinical Global Impression-Severity-Severe Mood Dysregulation | Placebo | Baseline | 3.62 | Standard Error .48 | units on a scale |
| Clinical Global Impression-Severity-Severe Mood Dysregulation | Open Lisdexamfetamine | Baseline | 4.30 | Standard Error .32 | units on a scale |
| Clinical Global Impression-Severity-Severe Mood Dysregulation | Fluoxetine | Week 4 | 4.42 | Standard Error .34 | units on a scale |
| Clinical Global Impression-Severity-Severe Mood Dysregulation | Placebo | Week 4 | 4.57 | Standard Error .31 | units on a scale |
| Clinical Global Impression-Severity-Severe Mood Dysregulation | Open Lisdexamfetamine | Week 4 | 4.31 | Standard Error .19 | units on a scale |
| Clinical Global Impression-Severity-Severe Mood Dysregulation | Fluoxetine | Week 5 | 4.15 | Standard Error .36 | units on a scale |
| Clinical Global Impression-Severity-Severe Mood Dysregulation | Placebo | Week 5 | 3.51 | Standard Error .32 | units on a scale |
| Clinical Global Impression-Severity-Severe Mood Dysregulation | Fluoxetine | Week 6 | 3.67 | Standard Error .34 | units on a scale |
| Clinical Global Impression-Severity-Severe Mood Dysregulation | Placebo | Week 6 | 3.90 | Standard Error .33 | units on a scale |
| Clinical Global Impression-Severity-Severe Mood Dysregulation | Fluoxetine | Week 7 | 3.61 | Standard Error .37 | units on a scale |
| Clinical Global Impression-Severity-Severe Mood Dysregulation | Placebo | Week 7 | 3.59 | Standard Error .34 | units on a scale |
| Clinical Global Impression-Severity-Severe Mood Dysregulation | Fluoxetine | Week 8 | 3.42 | Standard Error .39 | units on a scale |
| Clinical Global Impression-Severity-Severe Mood Dysregulation | Placebo | Week 8 | 3.37 | Standard Error .34 | units on a scale |
| Clinical Global Impression-Severity-Severe Mood Dysregulation | Fluoxetine | Week 10 | 3.45 | Standard Error .42 | units on a scale |
| Clinical Global Impression-Severity-Severe Mood Dysregulation | Placebo | Week 10 | 3.11 | Standard Error .35 | units on a scale |
| Clinical Global Impression-Severity-Severe Mood Dysregulation | Fluoxetine | Week 12 | 3.51 | Standard Error .38 | units on a scale |
| Clinical Global Impression-Severity-Severe Mood Dysregulation | Placebo | Week 12 | 3.30 | Standard Error .36 | units on a scale |
| ADHD-IV Rating Scale | Fluoxetine | Baseline | 34.50 | Standard Error 1.97 | units on a scale |
| ADHD-IV Rating Scale | Placebo | Baseline | 34.31 | Standard Error 1.87 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01714310/results